This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Aminoglutethimide

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Aminoglutethimide Means in Everyday Medical Language

Aminoglutethimide is a medicine that lowers the levels of certain hormones in the body, especially sex hormones like estrogen and testosterone. These hormones can sometimes help certain cancers grow. Aminoglutethimide works by blocking an enzyme called aromatase, which the body uses to make estrogen. Because of this, it belongs to a group of drugs called nonsteroidal aromatase inhibitors. By reducing hormone production, aminoglutethimide can slow or stop the growth of tumors that depend on these hormones.

Why Aminoglutethimide Can Matter in Cancer Care

Some cancers, such as certain breast and prostate cancers, need hormones to grow and spread. Hormone therapy aims to lower hormone levels or block their effects to control cancer growth. Aminoglutethimide is one of several drugs used to lower hormone levels. It is often combined with other medicines to prevent side effects related to hormone changes. While aminoglutethimide was used more in the past, newer drugs with better effectiveness and fewer side effects have mostly replaced it. Still, it may be considered when other treatments are not suitable or have stopped working.

What Patients Might See or Hear About Aminoglutethimide

Patients might hear the term aminoglutethimide during conversations about hormone-sensitive cancers or see it listed in treatment plans, medical reports, or drug information sheets. It may also appear in descriptions of clinical trials testing hormone-lowering treatments. Seeing the name can feel confusing because it sounds technical and is less commonly used today. It’s important to know that just because aminoglutethimide is mentioned, it doesn’t mean it will definitely be part of a patient’s treatment. Doctors consider many factors before choosing hormone therapies.

How Aminoglutethimide Fits Into Diagnosis and Treatment Planning

Doctors use tests to check if a cancer has hormone receptorsproteins that allow hormones to affect tumor growth. If a tumor is hormone receptor-positive, hormone therapy like aminoglutethimide might be an option. Aminoglutethimide works by lowering hormone production rather than blocking hormone receptors directly. It is often given with corticosteroids to reduce side effects. While it can help control hormone-sensitive cancers, it is usually not the first choice today. Instead, it may be used if other hormone therapies are not effective or suitable.

Common Confusions and Related Terms

Aminoglutethimide is a nonsteroidal aromatase inhibitor, which means it blocks the enzyme aromatase to lower estrogen levels. It is different from steroidal aromatase inhibitors and other hormone-blocking drugs like tamoxifen or leuprolide, which work in other ways. Patients may hear several hormone therapy drug names that sound similar or are mentioned together, which can be overwhelming. Asking the care team to explain how aminoglutethimide compares to other treatments can help clear up confusion.

Questions Patients Can Ask Their Care Team

Patients may want to ask how aminoglutethimide fits into their treatment plan, what side effects to expect, and how it compares to other hormone therapies. It’s also helpful to ask about how the medicine will be given, how long treatment might last, and what monitoring will be done. If patients take other medications or supplements, discussing possible interactions is important. Clear communication helps patients feel more in control and supported during treatment.

Understanding Aminoglutethimide in Context

When you see aminoglutethimide mentioned, it usually relates to hormone-sensitive cancers where lowering estrogen or testosterone can slow tumor growth. It may be part of combination therapy or used when hormone levels need to be controlled. The drug’s mention alone doesn’t provide the full picture. It’s best understood alongside information about your diagnosis, other treatments, and your doctor’s goals. If it appears in clinical trial descriptions, it may mean the study is exploring hormone-lowering strategies.

Safety and Next Steps

This information about aminoglutethimide is educational and does not replace personalized medical advice. The drug affects hormone production, which can impact many body systems, so it must be used carefully under medical supervision. Side effects, dosing, and suitability depend on your specific cancer type, overall health, and other treatments. Never start, stop, or change your medication without talking to your care team. If you have questions or concerns, ask your healthcare providers to explain how aminoglutethimide fits into your care and what to expect. Staying informed and communicating openly supports your safety and helps your care team provide the best support throughout your cancer journey.

Sources

Public source information used for this glossary entry includes: